Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 1.030
+0.005 (0.49%)
Jul 25, 2025, 4:10 PM AEST
Artrya Market Cap
Artrya has a market cap or net worth of 117.12 million as of July 25, 2025. Its market cap has increased by 495.22% in one year.
Market Cap
117.12M
Enterprise Value
110.14M
Revenue
13.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.03
Market Cap Chart
Since November 26, 2021, Artrya's market cap has decreased from 119.12M to 117.12M, a decrease of -1.68%. That is a compound annual growth rate of -0.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 117.12M | 141.56% |
| Dec 31, 2024 | 48.48M | 156.86% |
| Dec 29, 2023 | 18.88M | -39.81% |
| Dec 30, 2022 | 31.36M | -69.23% |
| Dec 31, 2021 | 101.94M | -14.43% |
| Nov 26, 2021 | 119.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.81B |
| Pro Medicus | 34.29B |
| Cochlear | 20.29B |
| Sonic Healthcare | 13.62B |
| Ramsay Health Care | 8.98B |
| Telix Pharmaceuticals | 8.50B |
| Ansell | 4.45B |
| Mesoblast | 2.92B |